Monday: I'm planning what I will say when Target Ovarian Cancer gives evidence to the committee of MPs that is scrutinising the Health and Social Care Bill on Thursday. There's lots of opportunity for progress, but I've got to make sure I get our concerns across.Tuesday: The fundraising manager tells me that 80 per cent of tickets have been sold for our comedy and music nights in memory of the Radio 4 comedian Linda Smith, who died of ovarian cancer in 2006. Many of Linda's friends are on the bill: Rory Bremner, Jo Brand, Maureen Lipman and Sandi Toksvig. I've got my fingers and toes crossed for two sell-out gigs later this month.
Wednesday: I'm grateful to the team for the cups of tea accompanied by the ubiquitous biscuit that arrive unbidden while I refine my thoughts on what I'll say to MPs tomorrow. It's incredible how many biscuits we get through in this office, and consumption correlates to peaks in activity. I'm feeling a bit nervous about tomorrow's event. It's a big opportunity to get MPs to amend the NHS bill - I don't want to waste it.
Thursday: I work from home this morning to prepare for this afternoon's meeting. My plan is to drive into London and on the way pick up Jenny Bogle, one of our supporters with ovarian cancer who is also giving evidence. It turns out to be a tough session and I'm exhausted afterwards, though we certainly had plenty of opportunity to put our point across. We'll have to wait and see what comes of it.
Friday: I make a start on my three-year medical research funding strategy. It's a priority for us because there have to be more treatments for ovarian cancer. I also tie up some loose ends with a Department of Health official after a meeting earlier in the week about NHS policy. I'm looking forward to a night out with some old friends, which inevitably means lots of Rioja. I hope this time my contact lenses won't end up in the microwave.
Target Ovarian Cancer campaigns for better diagnosis and treatment of women with ovarian cancer in the UK.
Annwen Jones is chief executive of Target Ovarian Cancer